Influence-Tools/republic-os
1
0
Fork 0
Code Issues Pull Requests Actions Packages Projects Releases Wiki Activity
Files
main
republic-os/legislation/us/states/va/2020/hb-908.md
T
Fabio 5a13be122b Legislation: batch E — CA TN VA VT WA WI WV WY 
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
2026-07-06 17:28:36 -04:00

7.2 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Naloxone; possession and administration by employee or person acting on behalf of a public place. Naloxone; possession and administration; employee or person acting on behalf of a public place. Authorizes an employee or other person acting on behalf of a public place, as defined in the bill, who has completed a training program on the administration of naloxone or other opioid antagonist to possess and administer naloxone or other opioid antagonist, other than naloxone in an injectable formulation with a hypodermic needle or syringe, in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health. The bill also provides that a person who is not otherwise authorized to administer naloxone or other opioid antagonist used for overdose reversal may administer naloxone or other opioid antagonist used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose. The bill provides immunity from civil liability for a person who, in good faith, administers naloxone or other opioid antagonist used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose, unless such act or omission was the result of gross negligence or willful and wanton misconduct. This bill incorporates HB 650, HB 1465, and HB 1466. us/states/va Virginia General Assembly 2020 HB 908 Virginia HB 908 (2020)
bill
enacted
C.E. Cliff Hayes, Jr.
4 30 6 2020-01-07 2020-04-09 openstates ocd-bill/8cf2dbe1-bfde-4fd4-b1fd-36fddcb36e1e https://lis.virginia.gov/cgi-bin/legp604.exe?201+sum+HB908 610682d767760f20059d65074d6a96f4fbd483b15007922f3e05c22fa829ab12 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-va

Virginia HB 908 (2020) — Naloxone; possession and administration by employee or person acting on behalf of a public place.

Naloxone; possession and administration; employee or person acting on behalf of a public place. Authorizes an employee or other person acting on behalf of a public place, as defined in the bill, who has completed a training program on the administration of naloxone or other opioid antagonist to possess and administer naloxone or other opioid antagonist, other than naloxone in an injectable formulation with a hypodermic needle or syringe, in accordance with protocols developed by the Board of Pharmacy in consultation with the Board of Medicine and the Department of Health. The bill also provides that a person who is not otherwise authorized to administer naloxone or other opioid antagonist used for overdose reversal may administer naloxone or other opioid antagonist used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose. The bill provides immunity from civil liability for a person who, in good faith, administers naloxone or other opioid antagonist used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose, unless such act or omission was the result of gross negligence or willful and wanton misconduct. This bill incorporates HB 650, HB 1465, and HB 1466.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. Acts of Assembly Chapter text (CHAP0924) (committee substitute) — source
  2. Bill text as passed House and Senate (HB908ER) (committee substitute) — source
  3. Engrossed by House - committee substitute HB908H1 (committee substitute) — source
  4. Impact statement from DPB (HB908) (committee substitute) — source

Votes

  • Constitutional reading dispensed (37-Y 0-N) — 37–0 (pass) · upper
  • Reported from Education and Health (14-Y 0-N) — 14–0 (pass) · upper
  • Passed Senate (40-Y 0-N) — 40–0 (pass) · upper
  • VOTE: Block Vote Passage (100-Y 0-N) — 99–0 (pass) · lower
  • Subcommittee recommends reporting with substitute (6-Y 0-N) — 6–0 (pass) · lower
  • Reported from Health, Welfare and Institutions with substitute (22-Y 0-N) — 22–0 (pass) · lower

Sponsors

  • C.E. Cliff Hayes, Jr. — primary (person)
  • Elizabeth R. Guzman — cosponsor (person)
  • Patrick A. Hope — cosponsor (person)
  • Sam Rasoul — cosponsor (person)
  • Wendy W. Gooditis — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2020-01-07 Prefiled and ordered printed; offered 01/08/20 20104833D introduction
  • 2020-01-07 Referred to Committee on Health, Welfare and Institutions referral-committee
  • 2020-01-16 Impact statement from DPB (HB908)
  • 2020-01-20 Assigned HWI sub: Health Professions referral-committee
  • 2020-01-30 Subcommittee recommends reporting with substitute (6-Y 0-N)
  • 2020-02-04 Committee substitute printed 20107306D-H1 substitution
  • 2020-02-04 Incorporates HB 1465 (Gooditis)
  • 2020-02-04 Incorporates HB1466 (Gooditis)
  • 2020-02-04 Incorporates HB650 (Hope)
  • 2020-02-04 Reported from Health, Welfare and Institutions with substitute (22-Y 0-N) committee-passage
  • 2020-02-05 Read first time reading-1
  • 2020-02-06 Read second time reading-2
  • 2020-02-06 Committee substitute agreed to 20107306D-H1
  • 2020-02-06 Engrossed by House - committee substitute HB908H1
  • 2020-02-07 Read third time and passed House BLOCK VOTE (100-Y 0-N) passage, reading-3
  • 2020-02-07 VOTE: Block Vote Passage (100-Y 0-N)
  • 2020-02-10 Impact statement from DPB (HB908H1)
  • 2020-02-10 Constitutional reading dispensed
  • 2020-02-10 Referred to Committee on Education and Health referral-committee
  • 2020-02-27 Reported from Education and Health (14-Y 0-N) committee-passage
  • 2020-02-28 Constitutional reading dispensed (37-Y 0-N)
  • 2020-03-02 Read third time reading-3
  • 2020-03-02 Passed Senate (40-Y 0-N) passage
  • 2020-03-05 Enrolled
  • 2020-03-05 Impact statement from DPB (HB908ER)
  • 2020-03-06 Signed by Speaker
  • 2020-03-06 Signed by President
  • 2020-03-12 Enrolled Bill communicated to Governor on March 12, 2020
  • 2020-03-12 Governor's Action Deadline 11:59 p.m., April 11, 2020
  • 2020-04-09 Approved by Governor-Chapter 924 (effective 7/1/20) executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/8cf2dbe1-bfde-4fd4-b1fd-36fddcb36e1e. Confidence: reported (aggregated from official Virginia legislature records).

Reference in New Issue View Git Blame Copy Permalink